Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT03902912
PHASE3

Effect of Prednisolone Treatment on Uterine Natural Killer Cells

Sponsor: Chinese University of Hong Kong

View on ClinicalTrials.gov

Summary

This study aims to investigate the role of uNK cells and the association with prednisolone.

Official title: Effect of Prednisolone Treatment on Uterine Natural Killer Cells and Endometrial Angiogenesis in Recurrent Miscarriage Around the Time of Embryo Implantation

Key Details

Gender

FEMALE

Age Range

18 Years - 40 Years

Study Type

INTERVENTIONAL

Enrollment

84

Start Date

2019-07-30

Completion Date

2028-04-30

Last Updated

2025-03-21

Healthy Volunteers

Yes

Interventions

DRUG

Prednisolone

prednisolone oral 10 mg/day from day one of the subsequent menstrual cycle to day LH 7 of that cycle. Then, the participants will be given a tailing off dose of 5 mg/day for 3 days followed by 2 mg/day for 3 days and then 1 mg/day for 3 days.

Locations (1)

The Chinese University of Hong Kong

Hong Kong, Hong Kong